Research interests
Professor Duan's research focuses on developing nucleic acid aptamer technology platforms for cancer biotechnology, focusing on cancer stem cell-targeted drug, siRNA and miRNA delivery using nanoparticles as well as aptamer-based molecular imaging for early detection of cancer and accurate staging. He heads a cross-disciplinary and translational research team consisting of cancer biologists, oncologists, molecular and cell biologists, material scientists, organic chemists, drug developers, pharmaceutical scientists and mechanical and electronic engineers across several faculties, research centres and teaching hospitals in Deakin. He is also involved in developing novel aptamer-based and microfluidic lab-on-a-chip devices for the application in biodefense, forensic medicine and rapid diagnostics at the point of care. He has published over 160 peer-reviewed original research papers and review articles in international refereed journals, with an h-index of 30 (average citation per article of 25). Professor Duan has filed 5 international patents on cancer stem related aptamers. He serves as the Editor-in-Chief for the journal “Drug Design, Development and Therapy” (https://www.dovepress.com/drug-design-development-and-therapy-journal).
Professors Duan has been frequently invited to address international conferences on biomedical research, drug development and molecular medicine.
6. Wei Duan, “Aptamer therapeutics: the 21st century’s magic bullet of nanomedicine”, Second International Conference on Drug Discovery and Therapy'. Feb 1-4, 2010. Dubai, United Arab Emirates.
8. Wei Duan, RNA Aptamer: The Next Generation of Cancer Stem Cell-targeted Molecular Imaging, BIT’s 9th Annual Congress of International Drug Discovery Science and Technology, Nov 3-6, 2011, Shenzhen, China;
10. Wei Duan, RNA aptamer-guided nanodrug delivery for the 21st century cancer medicine, 6th Annual Meeting of the Australian chapter of the Controlled Release Society, Melbourne, Nov 26-27, 2012.
11. Wei Duan, “Aptamer-guided nano drug delivery systems for cancer therapy”, Nano- and Microparticle-based drug and vaccine delivery, The 6th Joint Australia-New Zealand chapters of the Controlled Release Society, Brisbane, July 4-5, 2013.
12. W. Duan, “The use of RNA aptamers for diagnosis: detecting low levels of EpCAM in paraffin embedded tissues“, Aptamer in Medicine and Perspectives, Oct 4-5, 2013, Naples, Italy.
13. D.Xiang. S. Shigdar, W. Duan, “Targeting cancer stem cells in vivo using RNA aptamers“, 16th International Symposium on Molecular Medicine/The 18th World Congress on Advances in Oncology, 10-12, October, 2013, Hotel Creta Maris Resort, Greece.
15. T Wang, S Shigdar, Wei Duan, “An aptamer-based siRNA in vivo delivery system targeting cancer stem cells, 5th FIP Pharmaceutical Sciences World Congress, Melbourne, Australia, April 13-16, 2014.
16. Shigdar S, Xiang D, Duan W. Aptamers as effective cancer stem cell targeting modalities. Aptamers- 2014, 24-25th March 2014, Oxford, UK. Aug 25-27, 2015.
17. Wei Duan, “Cancer stem cells targeted delivery of siRNA in vivo: translating Nobel Prize-winning technology to clinic”, 8th Dubai International Conference for Medical Sciences, Ded15-17, 2014, Dubai, United Arab Emirates.
18. Wei Duan, “Cancer stem cell targeted delivery of siRNA to overcome induced chemoresistance”, European Pharma Congress, Aug 25-27, 2015, Valencia, Spain.
19. Wei Duan, “RNA aptamer-guided in vivo RNAi to overcome chemoresistance”, Health forum of the Silk Road-Int Summit Forum of Research and Development on Traditional Chinese Medicine and Ethnic Medicine, Oct 17-18, 2015, Kunlun Hotel, Urumuqi, Xingjiang, P.R. China.
Knowledge areas
aptamer, chemical antibody, molecular cell bioogy, cancer stem cell, targeted drug delivery, nanomedicine, nanotechnology, novel cancer treatment and diagnostics
Conferences
Media appearances
Being an Australian leader in developing aptamers against cancer stem cells, Professor Duan is well recognised for his innovative and translational medical research. For example, his work of developing RNA aptamer for cancer diagnosis and treatment was cited by Senator Kim Carr (Minister for Innovation), in his press release on 7 January 2011 as a fine example of the world-class research carried out by Australian leading researchers funded by the Department of Innovation, Industry, Science and Research, Australian Government.
(http://www.industry.gov.au/science/internationalcollaboration/Documents/Cancer_Diagnostics_Case_Study.pdf)
In addition, Professor Duan’s work has enjoined wide coverage by both domestic and international media (for a TV interview: http://www.youtube.com/watch?feature=player_embedded&v=cn_up61UnQY#at=244).
Newspaper coverage of Professor Duan's research:
1) The Australian newspaper, March 19, 2011, Article by Reporter Alexander Gambotto-Burke.
2) The Age newspaper, Melbourne: July 5, 2010, Article by Reporter Danny Rose.
3) Australian Broadcast Corporation, National Australia Radio, March 11, 2011, Interview with Desley Blanch.
4) Australian Broadcast Corporation, Melbourne Radio, February 17 (17:35), Prime time Interview with Lindy Burns.
5) Victoria TV Channel 31: Special features at 18:30, 9 March 2011, Length: 7 min 42 sec.
6) Geelong Advertiser: July 6, 2010, Article by Reporter Joel Cresswell.
7) Geelong Independent: February 25, 2011, Article by Erin Pearson.
Publications
In situ imaging miRNAs using multifunctional linear DNA nanostructure
H Xu, M Lin, Y Zheng, X Fang, X Huang, Q Huang, J Xu, W Duan, J Wei, L Jia
(2023), Vol. 253, Talanta, Netherlands, C1
The roles EpCAM plays to enhance the malignancy of gastric cancer
X Zhao, R Zhao, Y Feng, Z Qiu, X Bai, D Zhang, Y Zhou, H Fang, N Liu, L Chen, C Jia, Y Yuan, X Li, W Duan, G Nie, Y Hou
(2023), Journal of Cancer Research and Clinical Oncology, Berlin, Germany, C1
Ying Yang, Yu-Mei Zhang, Yan Wang, Kui Liu, Si-Yuan Cui, Ya-Qin Luo, Wei Zheng, Jie Xu, Wei Duan, Jing-Yi Wang
(2023), Vol. 44, pp. 418-425, Carcinogenesis, Oxford, England, C1
Zhaomin Feng, Da Huo, Shujuan Cui, Bing Lyu, Zhichao Liang, Fu Li, Peng Yang, Quanyi Wang, Daitao Zhang, Yang Pan, Wei Duan
(2023), Vol. 95, pp. 1-11, Journal of Medical Virology, London, Eng., C1-1
Development a novel drug delivery formulation targeting to esophageal squamous cell carcinoma
Y Feng, J Ge, D Zhang, X Bai, H Fang, Y Zhou, W Che, W Zhang, R Zhao, Z Qiu, X Zhao, L Xiao, H He, S Cheng, W Duan, R Wang, W Chen, G Nie, Y Hou
(2023), Vol. 19, pp. 1-9, Materials Today Advances, Amsterdam, The Netherlands, C1
Development of Blueberry-Derived Extracellular Nanovesicles for Immunomodulatory Therapy
T Nguyen, C Pham, R Chowdhury, S Patel, S Jaysawal, Y Hou, H Xu, L Jia, A Duan, P Tran, W Duan
(2023), Vol. 15, pp. 1-25, Pharmaceutics, Basel, Switzerland, C1
J Zhao, Y Peng, D Diaz-Dussan, J White, W Duan, L Kong, R Narain, X Hao
(2022), Vol. 19, pp. 1766-1777, Molecular Pharmaceutics, United States, C1
Q Zhang, H Huang, A Sun, C Liu, Z Wang, F Shi, W Duan, X Sun, Q Wang, P Sun, C Pu, Y Zhang
(2022), Vol. 10, pp. 390-397, Journal of Clinical and Translational Hepatology, China, C1
A novel navigated doxorubicin delivery formulation to breast cancer therapy
S Cheng, Z Lu, Y Feng, X Zhao, R Zhao, Z Qiu, C Jia, L Chen, Y Yuan, X Li, Q Gao, J Xu, Z Shu, W Duan, Y Hou, G Nie, L Xiao
(2022), Vol. 14, pp. 1-14, Materials Today Advances, Amsterdam, The Netherlands, C1
J Zhao, Y Peng, J Wang, D Diaz-Dussan, W Tian, W Duan, L Kong, X Hao, R Narain
(2022), Vol. 23, pp. 2552-2561, Biomacromolecules, Washington, D.C., C1
Q Gao, L Chen, C Jia, Y Yuan, X Li, Z Lu, Y Feng, R Zhao, X Zhao, Y Wang, S Cheng, C Zhang, J Xu, Z Shu, W Duan, G Nie, L Xiao, Y Hou
(2022), Vol. 44, pp. 951-960, Biotechnology Letters, Netherlands, C1
Inhibitory Effects of Myriocin on Non-Enzymatic Glycation of Bovine Serum Albumin
L He, Y Liu, J Xu, J Li, G Cheng, J Cai, J Dang, M Yu, W Wang, W Duan, K Liu
(2022), Vol. 27, pp. 1-18, Molecules, Basel, Switzerland, C1
W Yin, C Pham, T Wang, H Al Shamaileh, R Chowdhury, S Patel, Y Li, L Kong, Y Hou, Y Zhu, S Chen, H Xu, L Jia, W Duan, D Xiang
(2022), Vol. 12, pp. 1-14, Biomolecules, Basel, Switzerland, C1
A test-retest resting, and cognitive state EEG dataset during multiple subject-driven states
Yulin Wang, Wei Duan, Debo Dong, Lihong Ding, Xu Lei
(2022), Vol. 9, pp. 1-11, Scientific Data, London, Eng., C1-1
Xin Liu, Jiangtao Zhao, Guoqiang Qiu, Tahani Alahmadi, Sulaiman Alharbi, Milton Wainwright, Wei Duan
(2022), Vol. 71, pp. 587-597, JOURNAL OF OLEO SCIENCE, C1-1
Lihong Ding, Wei Duan, Yulin Wang, Xu Lei
(2022), Vol. 173, pp. 20-28, INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY, C1-1
Impaired alpha rhythm in bad sleeper during nap: A high-density electroencephalogram study
Xiangyue Zhao, Xinyuan Chen, Wei Duan, Wenrui Zhao, Xu Lei
(2022), Vol. 31, JOURNAL OF SLEEP RESEARCH, C1-1
X Zou, X Yang, Y Gan, D Liu, C Chen, W Duan, J Du
(2021), Vol. 16, pp. 306-317, Journal of Neuroimmune Pharmacology, United States, C1
H Jin, X Gao, L Xiao, H He, S Cheng, C Zhang, Y Hou, F Song, X Su, Q Gao, Z Lu, R Yang, X Song, J Yang, W Duan, Y Hou
(2021), Vol. 43, pp. 153-164, Biotechnology Letters, Netherlands, C1
J Zhao, D Diaz-Dussan, M Wu, Y Peng, J Wang, H Zeng, W Duan, L Kong, X Hao, R Narain
(2021), Vol. 22, pp. 800-810, Biomacromolecules, United States, C1
G Zhou, S Da Won Bae, R Nguyen, X Huo, S Han, Z Zhang, L Hebbard, W Duan, M Eslam, C Liddle, L Yuen, V Lam, L Qiao, J George
(2021), Vol. 501, pp. 124-132, Cancer Letters, Ireland, C1
M Wu, X Yang, L Xue, W Duan, J Du
(2021), Vol. 402, Behavioural Brain Research, Netherlands, C1
H He, F Song, Q Gao, Z Lu, Y Yuan, X Li, L Chen, C Jia, R Yang, J Yang, W Duan, Y Hou
(2021), Vol. 599, International Journal of Pharmaceutics, Netherlands, C1
X Meng, J Wang, J Zhou, Q Tian, B Qie, G Zhou, W Duan, Y Zhu
(2021), Vol. 127, pp. 266-275, Acta biomaterialia, Amsterdam, The Netherlands, C1
Cancer Stem Cell-Targeted Gene Delivery Mediated by Aptamer-Decorated pH-Sensitive Nanoliposomes
P Moitra, S Misra, K Kumar, P Kondaiah, P Tran, W Duan, S Bhattacharya
(2021), Vol. 7, pp. 2508-2519, ACS Biomaterials Science and Engineering, Washington, Eng., C1
The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells
W Yin, D Xiang, T Wang, Y Zhang, C Pham, S Zhou, G Jiang, Y Hou, Y Zhu, Y Han, L Qiao, P Tran, W Duan
(2021), Vol. 11, Scientific Reports, England, C1
C Pham, S Midge, H Barua, Y Zhang, T Ngoc-Gia Nguyen, R Barrero, A Duan, W Yin, G Jiang, Y Hou, S Zhou, Y Wang, X Xie, P Tran, D Xiang, W Duan
(2021), Vol. 708, Archives of Biochemistry and Biophysics, United States, C1
ITGB1 Enhances the Proliferation, Survival, and Motility in Gastric Cancer Cells
S Cheng, X Li, Y Yuan, C Jia, L Chen, Q Gao, Z Lu, R Yang, G Nie, J Yang, W Duan, L Xiao, Y Hou
(2021), Vol. 27, pp. 1192-1201, Microscopy and Microanalysis, C1
L Xiao, C Zhang, X Li, C Jia, L Chen, Y Yuan, Q Gao, Z Lu, Y Feng, R Zhao, X Zhao, S Cheng, Z Shu, J Xu, W Duan, G Nie, Y Hou
(2021), Vol. 22, International Journal of Molecular Sciences, Switzerland, C1
Yu-Xin Yang, Mei-Ling Wu, Ou Du, Wei Duan, Jun-Rong Du
(2021), Vol. 14, pp. 1628-+, International Journal of Clinical and Experimental Medicine, Madison, Wis., C1
Aptamer-mediated doxorubicin delivery reduces HCC burden in 3D organoids model
K Zhou, X Huo, R Nguyen, S Bae, S Han, Z Zhang, W Duan, L Yuen, V Lam, J George, L Qiao
(2021), Vol. 341, pp. 341-350, Journal of Controlled Release, Amsterdam, The Netherlands, C1
H Zheng, Y Gao, H Guo, L Li, Q Li, H Cui, A Lin, L Sun, Y Hu, S Kang, W Duan, L Pan, S Wang, Y Yang, Y Li, W Kong, Y Xiang, X Tian, B Ling, C Ha, W Bai
(2021), Vol. 20, pp. 1735-1742, Molecular Cancer Therapeutics, Philadelphia, Pass., C1-1
Wei Duan, Feizhang Qin, Dean Wu, Yunhong Dai
(2021), Vol. 161, MICROBIAL PATHOGENESIS, C1-1
Wei Duan, Xinyuan Chen, Ya-Jie Wang, Wenrui Zhao, Hong Yuan, Xu Lei
(2021), Vol. 348, JOURNAL OF NEUROSCIENCE METHODS, C1-1
Exosomes and nanoengineering: a match made for precision therapeutics
Phuong Tran, Dongxi Xiang, Thao Tran, Wang Yin, Yumei Zhang, Lingxue Kong, Kuisheng Chen, Miaomiao Sun, Yong Li, Yingchun Hou, Yimin Zhu, Wei Duan
(2020), Vol. 32, pp. 1-8, Advanced materials, Weinheim, Germany, C1
Development of conjugate-by-conjugate structured nanoparticles for oral delivery of docetaxel
P Ha-Lien Tran, T Wang, C Yang, T Tran, W Duan
(2020), Vol. 107, Materials Science and Engineering C, Netherlands, C1
P Tran, W Duan, T Tran
(2020), Vol. 575, International Journal of Pharmaceutics, Netherlands, C1
Current perspectives on delivery systems using extracellular vesicles in neurological disease
P Tran, W Duan, B Lee, T Tran
(2020), Vol. 26, pp. 764-771, Current pharmaceutical design, Sharjah, United Arab Emirates, C1
CD44 variant 6 is associated with prostate cancer growth and chemo-/radiotherapy response in vivo
J Ni, B Cheung, J Beretov, W Duan, J Bucci, D Malouf, P Graham, Y Li
(2020), Vol. 388, Experimental Cell Research, United States, C1
Aptamer-guided extracellular vesicle theranostics in oncology
P Tran, D Xiang, T Nguyen, T Tran, Q Chen, W Yin, Y Zhang, L Kong, A Duan, K Chen, M Sun, Y Li, Y Hou, Y Zhu, Y Ma, G Jiang, W Duan
(2020), Vol. 10, pp. 3849-3866, Theranostics, Australia, C1
CDKL3 promotes osteosarcoma progression by activating Akt/PKB
A He, L Ma, Y Huang, H Zhang, W Duan, Z Li, T Fei, J Yuan, H Wu, L Liu, Y Bai, W Dai, Y Wang, H Li, Y Sun, Y Wang, C Wang, T Yuan, Q Yang, S Tian, M Dong, R Sheng, D Xiang
(2020), Vol. 3, Life Science Alliance, United States, C1
D Bell, J Weber, W Yin, T Huynh, W Duan, R Zhou
(2020), Vol. 117, pp. 8486-8493, Proceedings of the National Academy of Sciences of the United States of America, Washington, D.C., C1
Roles of N-terminal Annexin A2 phosphorylation sites and miR-206 in colonic adenocarcinoma
L Xiao, H Jin, W Duan, Y Hou
(2020), Vol. 253, Life Sciences, Netherlands, C1
Emerging technologies for profiling extracellular vesicle heterogeneity
G Huang, G Lin, Y Zhu, W Duan, D Jin
(2020), Vol. 20, pp. 2423-2437, Lab on a Chip, London, Eng., C1
A Rasines Mazo, S Allison-Logan, F Karimi, N Chan, W Qiu, W Duan, N O'Brien-Simpson, G Qiao
(2020), Vol. 49, pp. 4737-4834, Chemical Society Reviews, England, C1
Y Gan, D Liu, C Chen, W Duan, Y Yang, J Du
(2020), Vol. 886, European Journal of Pharmacology, Netherlands, C1
Exosomes and breast cancer drug resistance
X Dong, X Bai, J Ni, H Zhang, W Duan, P Graham, Y Li
(2020), Vol. 11, Cell Death and Disease, England, C1
Facile Preparation of Macromolecular Prodrugs for Hypoxia-Specific Chemotherapy
J Zhao, D Diaz-Dussan, Z Jiang, Y Peng, J White, W Duan, R Narain, X Hao, L Kong
(2020), Vol. 9, pp. 1687-1692, ACS Macro Letters, United States, C1
Ying Sun, Peng Yang, Quanyi Wang, Li Zhang, Wei Duan, Yang Pan, Shuangsheng Wu, Huaqing Wang
(2020), Vol. 8, VACCINES, C1-1
Impaired Coupling of the Brain's Default Network During Sleep Deprivation: A Resting-State EEG Study
Ya-Jie Wang, Wei Duan, Xu Lei
(2020), Vol. 12, pp. 937-947, NATURE AND SCIENCE OF SLEEP, C1-1
Md Ali, Gong Zhen, Lambert Nzungize, Andrea Stojkoska, Xiangke Duan, Chunyan Li, Wei Duan, Junqi Xu, Jianping Xie
(2020), Vol. 10, FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, C1-1
Cao Ruan, Jiang Li, Jingjing Niu, Ping Li, Yu Huang, Xue Li, Wei Duan, Shuangquan Yan, Junfeng Zhen, Jianping Xie
(2020), Vol. 77, INFECTION GENETICS AND EVOLUTION, C1-1
Development of a novel drug targeting delivery system for cervical cancer therapy
Y Hou, L Xiao, N Ma, H He, J Li, S Cheng, Q Yang, Y Hou, F Song, H Jin, X Su, J Dong, R Zuo, X Song, W Duan
(2019), Vol. 30, Nanotechnology, England, C1
T Wang, W Yin, H AlShamaileh, Y Zhang, P Tran, T Nguyen, Y Li, K Chen, M Sun, Y Hou, W Zhang, Q Zhao, C Chen, P Zhang, W Duan
(2019), Vol. 30, pp. 1-16, Human Gene Therapy Methods, United States, C1
C Zeng, T Yang, H Zhou, Y Zhao, X Kuang, W Duan, J Du
(2019), Vol. 78, pp. 18-28, Neurobiology of Aging, United States, C1
H He, L Xiao, S Cheng, Q Yang, J Li, Y Hou, F Song, X Su, H Jin, Z Liu, J Dong, R Zuo, X Song, Y Wang, K Zhang, W Duan, Y Hou
(2019), Vol. 25, pp. 950-960, Microscopy and Microanalysis, United States, C1
The use of zein in the controlled release of poorly water-soluble drugs
P Tran, W Duan, B Lee, T Tran
(2019), Vol. 566, pp. 557-564, International Journal of Pharmaceutics, Netherlands, C1
P Tran, T Wang, W Yin, T Tran, H Barua, Y Zhang, S Midge, T Nguyen, B Lee, W Duan
(2019), Vol. 566, pp. 697-707, International Journal of Pharmaceutics, Netherlands, C1
Nanogels for skin cancer therapy via transdermal delivery: current designs
P Tran, W Duan, B Lee, T Tran
(2019), Vol. 20, pp. 575-582, Current drug metabolism, Beijing, China, C1
P Tran, W Duan, B Lee, T Tran
(2019), Vol. 25, pp. 2099-2107, Current Pharmaceutical Design, United Arab Emirates, C1
P Tran, W Duan, B Lee, T Tran
(2019), Vol. 569, International Journal of Pharmaceutics, Netherlands, C1
Recent developments of nanoparticle-delivered dosage forms for buccal delivery
P Tran, W Duan, T Tran
(2019), Vol. 571, International Journal of Pharmaceutics, Netherlands, C1
Aspirin-loaded nanoexosomes as cancer therapeutics
P Tran, T Wang, W Yin, T Tran, T Nguyen, B Lee, W Duan
(2019), Vol. 572, International Journal of Pharmaceutics, Netherlands, C1
Mycobacterium tuberculosis Rv1473 is a novel macrolides ABC Efflux Pump regulated by WhiB7
Wei Duan, Xue Li, Yan Ge, Zhaoxiao Yu, Ping Li, Jiang Li, Lianhua Qin, Jianping Xie
(2019), Vol. 14, pp. 47-59, FUTURE MICROBIOLOGY, C1-1
X She, L Chen, Z Yi, C Li, C He, C Feng, T Wang, S Shigdar, W Duan, L Kong
(2018), Vol. 18, pp. 976-989, Mini-Reviews in Medicinal Chemistry, Netherlands, C1
K Tran, T Van Vo, B Lee, W Duan, P Tran, T Tran
(2018), Vol. 15, pp. 576-584, Current Drug Delivery, United Arab Emirates, C1
Aptamers as potential therapeutic agents for ovarian cancer
J Henri, J Macdonald, M Strom, W Duan, S Shigdar
(2018), Vol. 145, pp. 34-44, Biochimie, Amsterdam, The Netherlands, C1
Mesoporous silica nanorods toward efficient loading and intracellular delivery of siRNA
L Chen, X She, T Wang, S Shigdar, W Duan, L Kong
(2018), Vol. 20, Journal of Nanoparticle Research, C1
Z Liu, J Liu, T Wang, Q Li, P Francis, C Barrow, W Duan, W Yang
(2018), Vol. 6, pp. 1251-1259, Journal of Materials Chemistry B, England, C1
Aptamers as targeting ligands and therapeutic molecules for overcoming drug resistance in cancers
G Zhou, O Latchoumanin, L Hebbard, W Duan, C Liddle, J George, L Qiao
(2018), Vol. 134, pp. 107-121, Advanced drug delivery reviews, Amsterdam, The Netherlands, C1
Current designs of polymer blends in solid dispersions for improving drug bioavailability
P Tran, W Duan, B Lee, T Tran
(2018), Vol. 19, pp. 1111-1118, Current Drug Metabolism, Netherlands, C1
J Ni, P Cozzi, J Beretov, W Duan, J Bucci, P Graham, Y Li
(2018), Vol. 18, BMC Cancer, England, C1
RNA aptamers-guided precision cancer medicine
W Duan, T Wang, S Shigdar, P Tran
(2018), Vol. 63, pp. 529-535, BME6 2016 : 6th International Conference on the Development of Biomedical Engineering in Vietnam, Ho Chi Minh City, Vietnam, E1
Challenges and opportunities for siRNA-based cancer treatment
T Wang, S Shigdar, H Shamaileh, M Gantier, W Yin, D Xiang, L Wang, S Zhou, Y Hou, P Wang, W Zhang, C Pu, W Duan
(2017), Vol. 387, pp. 77-83, Cancer Letters, Ireland, C1
Sonication-assisted nanoprecipitation in drug delivery
A Vo, T Luu, M Nguyen, T Vo, W Duan, P Tran, T Tran
(2017), Vol. 18, pp. 145-156, Current Drug Metabolism, Netherlands, C1
J Macdonald, J Henri, L Goodman, D Xiang, W Duan, S Shigdar
(2017), Vol. 8, pp. 777-784, ACS Chemical Neuroscience, United States, C1
Strategies of engineering nanoparticles for treating neurodegenerative disorders
K Nguyen, M Pham, T Van Vo, W Duan, P Tran, T Truong-Dinh Tran
(2017), Vol. 18, pp. 786-797, Current Drug Metabolism, Netherlands, C1
Predictive value of UGT1A1*28 polymorphism in irinotecan-based chemotherapy
X-H Liu, J Lu, W Duan, Z-M Dai, M Wang, S Lin, P-T Yang, T Tian, K Liu, Y-Y Zhu, Y Zheng, Q-W Sheng, Z-J Dai
(2017), Vol. 8, pp. 691-703, Journal of cancer, Wyoming, N.S.W., C1
Nanotechnology in neuroscience and its perspective as gene carrier
T Khanh, D Wei, P Tran, T Tran
(2017), Vol. 17, pp. 1379-1389, Current Topics in Medicinal Chemistry, United Arab Emirates, C1-1
L Xiao, H He, L Ma, M Da, S Cheng, Y Duan, Q Wang, H Wu, X Song, W Duan, Z Tian, Y Hou
(2017), Vol. 48, pp. 27-34, Archives of medical research, Amsterdam, The Netherlands, C1
P Moitra, K Kumar, S Sarkar, P Kondaiah, W Duan, S Bhattacharya
(2017), Vol. 53, pp. 8184-8187, Chemical Communications, England, C1
Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells
H Alshamaileh, T Wang, D Xiang, W Yin, P Tran, R Barrero, P Zhang, Y Li, L Kong, K Liu, S Zhou, Y Hou, S Shigdar, W Duan
(2017), Vol. 7, Scientific Reports, England, C1
H Dinh, P Tran, W Duan, B Lee, T Tran
(2017), Vol. 533, pp. 93-98, International Journal of Pharmaceutics, Netherlands, C1
Aptamer-based therapeutic approaches to target cancer stem cells
G Zhou, O Latchoumanin, M Bagdesar, L Hebbard, W Duan, C Liddle, J George, L Qiao
(2017), Vol. 7, pp. 3948-3961, Theranostics, Australia, C1
Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery
D Xiang, S Shigdar, A Bean, M Bruce, W Yang, M Mathesh, T Wang, W Yin, P Tran, H Shamaileh, R Barrero, P Zhang, Y Li, L Kong, K Liu, S Zhou, Y Hou, A He, W Duan
(2017), Vol. 7, pp. 4071-4086, Theranostics, Australia, C1
Nanoprecipitation for poorly water-soluble drugs
T Nguyen, V Tran, W Duan, P Tran, T Tran
(2017), Vol. 18, pp. 1000-1015, Current Drug Metabolism, Netherlands, C1
Conjugation strategies for colonic delivery and its application in colorectal cancer therapy
P Tran, W Duan, T Tran
(2017), Vol. 18, pp. 1016-1019, Current drug metabolism, Beijing, China, C1
Aptamers and glioblastoma: Their potential use for imaging and therapeutic applications
E Hays, W Duan, S Shigdar
(2017), Vol. 18, International Journal of Molecular Sciences, Switzerland, C1
Influenza vaccination in preventing outbreaks in schools: A long-term ecological overview
Yang Pan, Quanyi Wang, Peng Yang, Li Zhang, Shuangsheng Wu, Yi Zhang, Ying Sun, Wei Duan, Chunna Ma, Man Zhang, Xingxing Zhang, C MacIntyre
(2017), Vol. 35, pp. 7133-7138, VACCINE, C1-1
Zhaoxiao Yu, Chenhui Zhang, Mingliang Zhou, Qiming Li, Hui Li, Wei Duan, Xue Li, Yonghong Feng, Jianping Xie
(2017), Vol. 50, pp. 319-329, INTERNATIONAL IMMUNOPHARMACOLOGY, C1-1
Yalin Li, Xueyan Liu, Wei Duan, Hua Tian, Guangming Zhu, Hao He, Shutong Yao, Shuying Yi, Wengang Song, Hua Tang
(2017), Vol. 18, pp. 188-198, EBIOMEDICINE, C1-1
Application of aptamers in histopathology
S Shigdar, L Lv, L Wang, W Duan
(2016), Vol. 1380, pp. 191-196, Nucleic acid aptamers : selection, characterization and application, New York, N.Y., B1
Development of a Sustained Release Solid Dispersion Using Swellable Polymer by Melting Method
T Nguyen, P Tran, T Van Vo, W Duan, T Truong-Dinh Tran
(2016), Vol. 33, pp. 102-109, Pharmaceutical Research, United States, C1
Development of drug-loaded chitosan-vanillin nanoparticles and its cytotoxicity against HT-29 cells
P-W Li, G Wang, Z-M Yang, W Duan, Z Peng, L-X Kong, Q-H Wang
(2016), Vol. 23, pp. 30-35, Drug delivery, Abingdon, Eng., C1
The Application of Aptamers for Immunohistochemistry
M Bauer, J Macdonald, J Henri, W Duan, S Shigdar
(2016), Vol. 26, pp. 120-126, Nucleic Acid Therapeutics, United States, C1
Aptamers: a promising chemical antibody for cancer therapy
G Zhou, G Wilson, L Hebbard, W Duan, C Liddle, J George, L Qiao
(2016), Vol. 7, pp. 13446-13463, Oncotarget, Albany, N.Y., C1
H Shi, L Xiao, W Duan, H He, L Ma, M Da, Y Duan, Q Wang, H Wu, X Song, Y Hou
(2016), Vol. 85, pp. 26-33, Micron, England, C1
Perspectives of engineered marine derived polymers for biomedical nanoparticles
K Tran, T Vo, W Duan, P Tran, T Tran
(2016), Vol. 22, pp. 2844-2856, Current Pharmaceutical Design, United Arab Emirates, C1
V Ngo, T Luu, T Van Vo, V Tran, W Duan, P Tran, T Tran
(2016), Vol. 67, pp. 1-7, Materials Science and Engineering C, Netherlands, C1
Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer
J Deng, L Wang, H Chen, J Hao, J Ni, L Chang, W Duan, P Graham, Y Li
(2016), Vol. 7, pp. 55771-55788, Oncotarget, Orchard Park, N.Y., C1
Investigation of fucoidan-oleic acid conjugate for delivery of curcumin and paclitaxel
U Phan, K Nguyen, T Vo, W Duan, P Tran, T Tran
(2016), Vol. 16, pp. 1281-1287, Anti-Cancer Agents in Medicinal Chemistry, Netherlands, C1
Truncation and Mutation of a Transferrin Receptor Aptamer Enhances Binding Affinity
J MacDonald, P Houghton, D Xiang, W Duan, S Shigdar
(2016), Vol. 26, pp. 348-354, Nucleic Acid Therapeutics, United States, C1
S He, L Shu, Z Zhou, T Yang, W Duan, X Zhang, Z He, S Zhou
(2016), Vol. 382, pp. 215-230, Cancer Letters, Ireland, C1
H Van Ngo, P Nguyen, T Van Vo, W Duan, V Tran, P Tran, T Tran
(2016), Vol. 513, pp. 148-152, International Journal of Pharmaceutics, Netherlands, C1
Proteomics discovery of chemoresistant biomarkers for ovarian cancer therapy
J Deng, L Wang, J Ni, J Beretov, V Wasinger, D Wu, W Duan, P Graham, Y Li
(2016), Vol. 13, pp. 905-915, Expert Review of Proteomics, England, C1
J Hao, P Graham, L Chang, J Ni, V Wasinger, J Beretov, J Deng, W Duan, J Bucci, D Malouf, D Gillatt, Y Li
(2016), Vol. 7, pp. 74269-74285, Oncotarget, United States, C1
Z Jin, W Duan, W Duan, B Liu, X Chen, F Yang, J Guo
(2016), Vol. 517, pp. 129-140, Applied Catalysis A: General, Amsterdam, The Netherlands, C1-1
Overexpression of p53 Improves Blood Glucose Control in an Insulin Resistant Diabetic Mouse Model
Xuemei Zhang, Wei Duan, Wai-Nang Lee, Yuewei Zhang, Fenfen Xiang, Qian Liu, Vay Go, Gary Xiao
(2016), Vol. 45, pp. 1010-1017, PANCREAS, C1-1
Cytokine networks and cancer stem cells
C Liongue, A Ward, W Duan, S Shigdar
(2015), pp. 67-87, Cancer stem cells : emerging concepts and future perspectives in translational oncology, Berlin, Germany, B1
A protocol for improving fabrication yield of thin SU-8 microcantilevers for use in an aptasensor
Y Lim, A Kouzani, A Kaynak, X Dai, G Littlefair, W Duan
(2015), Vol. 21, pp. 371-380, Microsystem technologies, Berlin, Germany, C1
Y Zhang, W Duan, L Owusu, D Wu, Y Xin
(2015), Vol. 35, pp. 117-124, International Journal of Molecular Medicine, Athens, Greece, C1
Y Qin, Z Zhou, S Pan, Z He, X Zhang, J Qiu, W Duan, T Yang, S Zhou
(2015), Vol. 327, pp. 62-76, Toxicology, Ireland, C1
D Xiang, S Shigdar, G Qiao, T Wang, A Kouzani, S Zhou, L Kong, Y Li, C Pu, W Duan
(2015), Vol. 5, pp. 23-42, Theranostics, Wyoming, N.S.W., C1
Aptamer-mediated cancer gene therapy.
D Xiang, S Shigdar, G Qiao, S Zhou, Y Li, M Wei, L Qiao, H Shamaileh, Y Zhu, C Zheng, C Pu, W Duan
(2015), Vol. 15, pp. 109-119, Current Gene Therapy, Bussum, Netherlands, C1
X She, L Chen, L Velleman, C Li, H Zhu, C He, T Wang, S Shigdar, W Duan, L Kong
(2015), Vol. 445, pp. 151-160, Journal of Colloid and Interface Science, United States, C1
Y Ding, Z Zhou, C Ha, X Zhang, S Pan, Z He, J Edelman, D Wang, Y Yang, X Zhang, W Duan, T Yang, J Qiu, S Zhou
(2015), Vol. 9, pp. 425-464, Drug Design, Development and Therapy, New Zealand, C1
J Li, Y Yang, Q Liu, Z Zhou, S Pan, Z He, X Zhang, T Yang, S Pan, W Duan, S He, X Chen, J Qiu, S Zhou
(2015), Vol. 9, pp. 1027-1062, Drug design, development and therapy, Macclesfield, Eng., C1
Y Wang, Y Yang, R Zhao, S Pan, H Zhe, Z He, W Duan, X Zhang, T Yang, J Qiu, S Zhou
(2015), Vol. 9, pp. 993-1026, Drug design, development and therapy, Auckland, New Zealand, C1
Clinical association between pharmacogenomics and adverse drug reactions
Z Zhou, X Chen, K Sneed, Y Yang, X Zhang, Z He, K Chow, T Yang, W Duan, S Zhou
(2015), Vol. 75, pp. 589-631, Drugs, Basel, Switzerland, C1
Sch9 regulates intracellular protein ubiquitination by controlling stress responses
B Qie, Z Lyu, L Lyu, J Liu, X Gao, Y Liu, W Duan, N Zhang, L Du, K Liu
(2015), Vol. 5, pp. 290-300, Redox biology, Amsterdam, The Netherlands, C1
Chansu inhibits the expression of cortactin in colon cancer cell lines in vitro and in vivo
C Li, S Hashimi, S Cao, J Qi, D Good, W Duan, M Wei
(2015), Vol. 15, pp. 1-8, BMC complementary and alternative medicine, London, Eng., C1
X Chen, Z He, Z Zhou, T Yang, X Zhang, Y Yang, W Duan, S Zhou
(2015), Vol. 42, pp. 999-1024, Clinical and experimental pharmacology and physiology, London, Eng., C1
S Shirbin, K Ladewig, Q Fu, M Klimak, X Zhang, W Duan, G Qiao
(2015), Vol. 16, pp. 2463-2474, Biomacromolecules, Washington, D.C., C1
X She, L Chen, L Velleman, C Li, C He, J Denman, T Wang, S Shigdar, W Duan, L Kong
(2015), Vol. 3, pp. 6094-6104, Journal of materials chemistry B, Cambridge, Eng., C1
D Xiang, C Zheng, S Zhou, S Qiao, P Tran, C Pu, Y Li, L Kong, A Kouzani, J Lin, K Liu, L Li, S Shigdar, W Duan
(2015), Vol. 5, pp. 1083-1097, Theranostics, Sydney, N.S.W., C1
X Chen, Z He, Z Zhou, T Yang, X Zhang, Y Yang, W Duan, S Zhou
(2015), Vol. 42, pp. 1225-1238, Clinical and experimental pharmacology and physiology, London, Eng., C1
L Chen, X She, T Wang, L He, S Shigdar, W Duan, L Kong
(2015), Vol. 7, pp. 14080-14092, Nanoscale, Cambridge, Eng., C1
Controllable drug uptake and nongenomic response through estrogen-anchored cyclodextrin drug complex
J Yin, S Shumyak, C Burgess, Z Zhou, Z He, X Zhang, S Pan, T Yang, W Duan, J Qiu, S Zhou
(2015), Vol. 10, pp. 4717-4730, International journal of nanomedicine, Auckland, N. Z., C1
N Niu, J Yin, Y Yang, Z Wang, Z Zhou, Z He, X Chen, X Zhang, W Duan, T Yang, S Zhou
(2015), Vol. 9, pp. 4441-4470, Drug design, development and therapy, Macclesfield, Eng., C1
Cancer stem cell targeted therapy: progress amid controversies
T Wang, S Shigdar, M Gantier,, Y Hou,, L Wang,, Y Li,, H Shamaileh,, W Yin, S Zhou,, X Zhao,, W Duan
(2015), Vol. 6, pp. 44191-44206, Oncotarget, Albany, N.Y., C1
T Wang, M Gantier, D Xiang, A Bean, M Bruce, S Zhou, M Khasraw, A Ward, L Wang, M Wei, H AlShamaileh, L Chen, X She, J Lin, L Kong, S Shigdar, W Duan
(2015), Vol. 5, pp. 1456-1472, Theranostics, Wyoming, N.S.W., C1
A surface-stress-based microcantilever aptasensor
Y Lim, A Kouzani, W Duan, X Dai, A Kaynak, D Mair
(2014), Vol. 8, pp. 15-24, IEEE transactions on biomedical circuits and systems, Piscataway, NJ, C1
J Lin, S Shigdar, D Fang, D Xiang, M Wei, A Danks, L Kong, L Li, L Qiao, W Duan
(2014), Vol. 9, pp. 1-13, Plos One, San Francisco, CA, C1
M Das, W Duan, S Sahoo
(2014), pp. 1-11, Nanomedicine : nanotechnology, biology and medicine, Amsterdam, The Netherlands, C1
Synergistic effects of IAP inhibitor LCL161 and paclitaxel on hepatocellular carcinoma cells.
A Tian, G Wilson, S Lie, G Wu, Z Hu, L Hebbard, W Duan, J George, L Qiao
(2014), Vol. 351, pp. 232-241, Cancer Letters, Ireland, C1
Y Li, S He, Z He, M Li, Y Yang, J Pang, X Zhang, K Chow, Q Zhou, W Duan, Z Zhou, T Yang, G Huang, A Liu, J Qiu, J Liu, S Zhou
(2014), Vol. 344, pp. 239-259, Cancer Letters, Shannon, County Clare, Ireland, C1
Cancer stem cells: a contentious hypothesis now moving forward
M O'Connor, D Xiang, S Shigdar, J Macdonald, Y Li, T Wang, C Pu, Z Wang, L Qiao, W Duan
(2014), Vol. 344, pp. 180-187, Cancer letters, Shannon, Ireland, C1
Cancer stem cells in prostate cancer chemoresistance
J Ni, P Cozzi, J Hao, W Duan, P Graham, J Kearsley, Y Li
(2014), Vol. 14, pp. 225-240, Current cancer drug targets, Bussum, Netherlands, C1
CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance
J Ni, P Cozzi, J Hao, J Beretov, L Chang, W Duan, S Shigdar, W Delprado, P Graham, J Bucci, J Kearsley, Y Li
(2014), Vol. 74, pp. 602-617, Prostate, Hoboken, NJ, C1
Z-X Wang, J Sun, C Howell, Q-Y Zhou, Z-X He, T Yang, H Chew, W Duan, Z-W Zhou, J Kanwar, S-F Zhou
(2014), Vol. 28, pp. 551-582, Fundamental and clinical pharmacology, Chichester, England, C1
L Wang, W Duan, L Kang, J Mao, X Yu, S Fan, L Li, Y Tao
(2014), Vol. 68, pp. 1099-1104, Biomedicine & pharmacotherapy, Amsterdam, The Netherlands, C1
Theoretical modeling and experimental validation of surface stress in thrombin aptasensor
Y Lim, A Kouzani, A Kaynak, X Dai, G Littlefair, W Duan
(2014), Vol. 13, pp. 384-391, IEEE Transactions on Nanobioscience, United States, C1
L Li, D Xiang, S Shigdar, W Yang, Q Li, J Lin, K Liu, W Duan
(2014), Vol. 9, pp. 1083-1096, International journal of nanomedicine, Macclesfield, England, C1
C Chen, Q Ma, C Liu, P Deng, G Zhu, L Zhang, M He, Y Lu, W Duan, L Pei, M Li, Z Yu, Z Zhou
(2014), Vol. 4, pp. 1-10, Scientific reports, London, Eng., C1-1
∝-mangostin inhibits hypoxia-driven ROS-induced PSC activation and pancreatic cancer cell invasion
J Lei, X Huo, W Duan, Q Xu, R Li, J Ma, X Li, L Han, W Li, H Sun, E Wu, Q Ma
(2014), Vol. 347, pp. 129-138, Cancer letters, Amsterdam, The Netherlands, C1-1
Design and evaluation of a microcantilever aptasensor
Y Lim, A Kouzani, W Duan, X Dai, A Kaynak, D Mair
(2014), pp. 221-224, ISCAS 2014 : Proceedings of the 2014 IEEE International Symposium on Circuits and Systems, Melbourne, Victoria, E1
Localized surface plasmon resonance: nano-sinusoid arrays
D Mortazavi, A Kouzani, L Matekovits, W Duan
(2013), Vol. 27, pp. 638-648, Journal of electromagnetic waves and applications, London, Eng., C1
M Stewart, P Stewart, M Sroyraya, N Soonklang, S Cummins, P Hanna, W Duan, P Sobhon
(2013), Vol. 164, pp. 276-290, Comparative biochemistry and physiology. Part A : molecular & integrative physiology, New York, N.Y., C1
RNA aptamers targeting cancer stem cell marker CD133
S Shigdar, L Qiao, S Zhou, D Xiang, T Wang, Y Li, L Lim, L Kong, L Li, W Duan
(2013), Vol. 330, pp. 84-95, Cancer letters, Amsterdam, Netherlands, C1
S Shigdar, C Qian, L Lv, C Pu, Y Li, L Li, M Marappan, J Lin, L Wang, W Duan
(2013), Vol. 8, pp. 1-8, PLoS One, San Diego, United States, C1
J Ni, P Cozzi, J Hao, J Beretov, L Chang, W Duan, S Shigdar, W Delprado, P Graham, J Bucci, J Kearsley, Y Li
(2013), Vol. 45, pp. 2736-2748, International journal of biochemistry and cell biology, Amsterdam, The Netherlands, C1
D Xiang, Z Yang, W Duan, X Li, J Yin, S Shigdar, M O'Connor, M Marappan, X Zhao, Y Miao, B Xiang, C Zheng
(2013), Vol. 8, pp. 4103-4114, International Journal of Nanomedicine, Macclesfield, UK, C1
Inflammation and cancer stem cells
S Shigdar, Y Li, S Bhattacharya, M O'Connor, C Pu, J Lin, T Wang, D Xiang, L Kong, M Wei, Y Zhu, S Zhou, W Duan
(2013), Vol. 345, pp. 271-278, Cancer letters, Amsterdam, The Netherlands, C1
Aptamers as theranostic agents: modifications, serum stability and functionalisation
S Shigdar, J Macdonald, M O'Connor, T Wang, D Xiang, H Al.Shamaileh, L Qiao, M Wei, S Zhou, Y Zhu, L Kong, S Bhattacharya, C Li, W Duan
(2013), Vol. 13, pp. 13624-13637, Sensors, Basel, Switzerland, C1
Y Song, Z Zhu, Y An, W Zhang, H Zhang, D Liu, C Yu, W Duan, C Yang
(2013), Vol. 85, pp. 4141-4149, Analytical chemistry, Washington DC, C1
J Yin, S Sharma, S Shumyak, Z Wang, Z Zhou, Y Zhang, P Guo, C Li, J Kanwar, T Yang, S Mohapatra, W Liu, W Duan, J Wang, Q Li, X Zhang, J Tan, L Jia, J Liang, M Wei, X Li, S Zhou
(2013), Vol. 8, pp. 1-20, PLOS one, San Francisco, California, C1
Peptide-fluorescent bacteria complex as luminescent reagents for cancer diagnosis
B Dong, A Wang, L Yuan, L Chen, K Pu, W Duan, X Yan, Y Zhu
(2013), Vol. 8, PLOS One, San Francisco, California, C1
Efficacy of using cancer stem cell markers in isolating and characterizing liver cancer stem cells
G Wilson, Z Hu, W Duan, A Tian, X Wang, D McLeod, V Lam, J George, L Qiao
(2013), Vol. 22, pp. 2655-2664, Stem Cells and Development, New Rochelle, NY, C1
Y Zhang, L Owusu, W Duan, T Jiang, S Zang, A Ahmed, Y Xin
(2013), Vol. 32, pp. 959-964, International journal of molecular medicine, Athens, Greece, C1
Tumoricidal effects of the JAK inhibitor Ruxolitinib (INC424) on hepatocellular carcinoma in vitro
G Wilson, A Tian, L Hebbard, W Duan, J George, X Li, L Qiao
(2013), Vol. 341, pp. 224-230, Cancer letters, Amsterdam, The Netherlands, C1
S Dawar, N Singh, R Kanwar, R Kennedy, R Veedu, S Zhou, S Krishnakumar, S Hazra, S Sasidharan, W Duan, J Kanwar
(2013), Vol. 18, pp. 1292-1300, Drug discovery today, London, England, C1
The mechanisms of Chansu in inducing efficient apoptosis in colon cancer cells
C Li, S Hashimi, S Cao, A Mellick, W Duan, D Good, M Wei
(2013), Vol. 2013, pp. 1-11, Evidence-based complementary and alternative medicine, New York, N. Y., C1
A Wang, K Pu, B Dong, Y Liu, L Zhang, Z Zhang, Duan Wei, Y Zhu
(2013), Vol. 33, pp. 1156-1164, Journal of applied toxicology, Bognor Regis, England, C1-1
Role of multidrug resistance associated proteins in drug development
S Zhou, J Liu, M Wei, W Duan
(2012), pp. 3-35, Multidrug resistance : a global concern, [San Francisco, Calif.], B1
S Shigdar, A Smith, W Duan
(2012), pp. 275-296, Nanotechnology in health care, Singapore, Singapore, B1-1
Developing lspr design guidelines
D Mortazavi, A Kouzani, A Kaynak, W Duan
(2012), Vol. 126, pp. 203-235, Progress in electromagnetics research, Cambridge, Mass., C1
Cancer stem cell targeting : the next generation of cancer therapy and molecular imaging
S Shigdar, J Lin, Y Li, C Yang, M Wei, Y Zhu, H Liu, W Duan
(2012), Vol. 3, pp. 227-244, Therapeutic delivery, London, England, C1
Clostridial spores for cancer therapy : targeting solid tumour microenvironment
B Umer, D Good, J Anne, W Duan, M Wei
(2012), Vol. 2012, pp. 1-8, Journal of toxicology, New York, N.Y., C1
J Lin, Y Yu, S Shigdar, D Fang, J Rong Du, M Wei, A Danks, K Liu, W Duan
(2012), Vol. 7, pp. 1-10, Plos One, San Francisco, Calif., C1-1
Apoptosis and microRNA aberrations in cancer
C Li, S Hashimi, D Good, S Cao, W Duan, P Plummer, A Mellick, M Wei
(2012), Vol. 39, pp. 739-746, Clinical and experimental pharmacology and physiology, Australia, C1
Role of the EpCAM (CD326) in prostate cancer metastasis and progression
J Ni, P Cozzi, W Duan, S Shigdar, P Graham, K John, Y Li
(2012), Vol. 31, pp. 779-791, Cancer metastasis reviews, New York, N. Y., C1
Cancer gene therapy : developments and future perspectives
D Good, W Duan, J Anne, M Wei
(2011), pp. 299-314, Gene therapy - Developments and Future Perspectives, Rijeka, Croatia, B1
J Lin, D Fang, J Du, S Shigdar, L Xiao, X Zhou, W Duan
(2011), Vol. 58, pp. 150-157, Annals of nutrition and metabolism, Basel, Switzerland, C1
Z Zhang, R Gong, J Du, L Xiao, W Duan, X Zhou, D Fang
(2011), Vol. 36, pp. 226-232, Applied physiology, nutrition and metabolism, Ottawa, Canada, C1
Clinical applications of aptamers and nucleic acid therapeutics in haematological malignancies
S Shigdar, A Ward, A De, C Yang, M Wei, W Duan
(2011), Vol. 155, pp. 3-13, British journal of haematology, Oxford, U. K., C1
Y Liu, S Mo, H Bi, B Hu, C Li, Y Wang, L Huang, M Huang, W Duan, J Liu, M Wei, S Zhou
(2011), Vol. 41, pp. 259-280, Xenobiotica, London, U. K., C1
X Huang, R Gong, J Lin, R Li, L Xiao, W Duan, D Fang
(2011), Vol. 5, pp. 198-204, Bioscience trends, Tokyo, Japan, C1
RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule
S Shigdar, J Lin, Y Yu, M Pastuovic, M Wei, W Duan
(2011), Vol. 102, pp. 991-998, Cancer Science, Tokyo, Japan, C1-1
A micromechanical biosensor with interdigitated capacitor readout
Y Lim, A Kouzani, A Kaynak, R Al-Ameri, W Duan
(2011), pp. 42-46, CME 2011 : Proceedings of the 2011 IEEE/ICME International Conference on Complex Medical Engineering, Harbin Heilongjiang, China, E1
Nano-plasmonic biosensors : a review
D Mortazavi, A Kouzani, A Kaynak, W Duan
(2011), pp. 31-36, CME 2011 : Proceedings of the 2011 IEEE/ICME International Conference on Complex Medical Engineering, Harbin Heilongjiang, China, E1
Y Lim, A Kouzani, W Duan
(2010), Vol. 6, pp. 93-105, Journal of biomedical nanotechnology, Valencia, Calif., C1
Lab-on-a-chip : a component view
Y Lim, A Kouzani, W Duan
(2010), Vol. 16, pp. 1995-2015, Microsystem technologies : sensors actuators systems integration, Heidelberg, Germany, C1
M Stewart, P Stewart, N Soonklang, V Linthong, P Hanna, W Duan, P Sobhon
(2010), Vol. 42, pp. 137-150, Tissue and cell, United Kingdom, C1
Disposition pathways and pharmacokinetics of herbal medicines in humans
S He, C Li, J Liu, E Chan, W Duan, S Zhou
(2010), Vol. 17, pp. 4072-4113, Current medicinal chemistry, Amsterdam, The Netherlands, C1
Aptamer therapeutics: the 21st century's magic bullet of nanomedicine
S Shigdar, J Luczo, M Wei, R Bell, A Danks, K Liu, D Wei
(2010), Vol. 1, pp. 118-124, Open conference proceedings journal, Bussum, The Netherlands, C1-1
J Du, D Fang, J Lin, L Xiao, X Zhou, S Shigdar, W Duan
(2010), Vol. 21, pp. 1114-1119, Journal of nutritional biochemistry, New York, N.Y., C1-1
Effects of design parameters on sensitivity of microcantilever biosensors
Y Lim, A Kouzani, W Duan, A Kaynak
(2010), pp. 177-181, IEEE/ICME 2010 : Proceedings of the 2010 International Conference on Complex Medical Engineering, Gold Coast, Australia, E1
Design and construction of a micropump for drug delivery applications
A Kouzani, M Ivankovic, M Fielding, A Kaynak, C Yang, W Duan, E Hu
(2010), pp. 182-187, IEEE/ICME 2010 : Proceedings of the 2010 International Conference on Complex Medical Engineering, Gold Coast, Australia, E1
Aptasensors design considerations
Y Lim, A Kouzani, W Duan
(2009), pp. 118-127, Computational intelligence and intelligent systems, Berlin, Germany, B1
W Zhang, A Smith, J Liu, N Cheung, S Zhou, K Liu, Q Li, W Duan
(2009), Vol. 21, pp. 237-245, Cellular signalling, Amsterdam, The Netherlands, C1
Substrate specificity, regulation, and polymorphism of human cytochrome P450 2B6
S Mo, Y Liu, W Duan, M Wei, J Kanwar, S Zhou
(2009), Vol. 10, pp. 730-753, Current drug metabolism, Hilversum, The Netherlands, C1
Insights into the Structure, Function, and Regulation of Human Cytochrome P450 1A2
S Zhou, L Yang, M Wei, W Duan, E Chan
(2009), Vol. 10, pp. 713-729, Current drug metabolism, Bussum, Netherlands, C1-1
S Zhou, L Wang, Y Di, C Xue, W Duan, C Li, Y Li
(2008), Vol. 15, pp. 1981-2039, Current medicinal chemistry, Schiphol, Netherlands, C1
The C-terminus of PRK2/PKNγ is required for optimal activation by RhoA in a GTP-dependent manner
W Lim, X Chen, J Liu, B Tan, S Zhou, A Smith, N Lees, L Hou, F Gu, X Yu, Y Du, D Smith, C Verma, K Liu, W Duan
(2008), Vol. 479, pp. 170-178, Archives of biochemistry and biophysics, New York, N.Y., C1
Clincial pharmacogenetics and potential application in personalized medicine
S Zhou, Y Di, E Chan, Y Du, V Chow, C Xue, X Lai, J Wang, C Li, M Tian, W Duan
(2008), Vol. 9, pp. 738-784, Current drug metabolism, Hilversum, Netherlands, C1
Ets2 maintains hTERT gene expression and breast cancer cell proliferation by interacting with c-Myc
D Xu, J Dwyer, L He, W Duan, J Liu
(2008), Vol. 283, pp. 23567-23580, Journal of biological chemistry, Bethesda, Md, C1
Protein kinase C isozymes as potential therapeutic targets in immune disorders
M Lee, W Duan, S Tan
(2008), Vol. 12, pp. 535-552, Expert opinion on therapeutic targets, London, England, C1
Emerging host cell targets for hepatitis C therapy
Y He, W Duan, S Tan
(2007), Vol. 12, pp. 209-217, Drug discovery today, Barking, England, C1
K Shao, Q Hou, M Go, W Duan, N Cheung, S Feng, K Wong, A Yoram, W Zhang, Z Huang, Q Li
(2007), Vol. 64, pp. 506-515, Cellular and molecular life sciences, Basel, Switzerland, C1
X Yu, S Lin, Z Zhou, X Chen, J Liang, P Liu, W Duan, B Chowbay, J Wen, S Zhou
(2007), Vol. 8, pp. 1-16, Current drug metabolism, Hilversum, The Netherlands, C1
X Yu, Z Zhou, S Lin, X Chen, X Yu, J Liang, W Duan, J Wen, X Li, S Zhou, B Chowbay, E Chan, J Cao, C Li, C Xue
(2007), Vol. 24, pp. 1668-1690, Pharmaceutical research, Delft, The Netherlands, C1
X Yu, Z Zhou, S Lin, X Chen, X Yu, J Liang, W Duan, J Wen, X Li, S Zhou
(2007), Vol. 37, pp. 375-415, Xenobiotica: the fate of foregn compounds in biological systems, Abingdon, England, C1
Z Hu, X Yang, X Chen, E Chan, W Duan, S Zhou
(2007), Vol. 850, pp. 575-580, Journal of chromatography. B, analytical technologies in the biomedical and life sciences, Amsterdam, Nertherlands, C1
M Stewart, N Soonklang, P Stewart, P Hanna, W Chaitip, A Parratt, W Duan, P Sobhon
(2007), Vol. 50, pp. 85-97, Invertebrate reproduction and development, Rehovot, Israel, C1
W Zhang, W Duan, N Cheung, Z Huang, K Shao, Q Li
(2007), Vol. 103, pp. 1157-1167, Journal of neurochemistry, Chichester, England, C1
X Yu, S Lin, Z Zhou, X Chen, J Liang, W Duan, X Yu, J Wen, B Chowbay, C Li, F Sheu, E Chan, S Zhou
(2007), Vol. 417, pp. 261-265, Neuroscience letters, Limerick, Ireland, C1
Design of new oxazaphosphorine anticancer drugs
J Liang, M Huang, W Duan, X Yu, S Zhou
(2007), Vol. 13, pp. 963-978, Current pharmaceutical design, Hilversum, The Netherlands, C1
A mechanistic study on altered pharmacokinetics of irinotecan by St. Johns wort
Z Hu, X Yang, X Chen, E Chan, W Duan, M Huang, X Yu, J Wen, S Zhou, J Cao
(2007), Vol. 8, pp. 157-171, Current drug metabolism, Hilversum, The Netherlands, C1
X Yu, S Lin, X Chen, Z Zhou, J Liang, W Duan, B Chowbay, J Wen, E Chan, J Cao, C Li, S Zhou
(2007), Vol. 8, pp. 365-377, Current drug metabolism, Hilversum, Netherlands, C1
J Cao, X Chen, J Liang, X-Q Yu, A-L Xu, E Chan, W Duan, M Huang, J-Y Wen, X-Y Yu, X-T Li, F-S Sheu, S-F Zhou
(2007), Vol. 35, pp. 539-553, Drug metabolism and disposition, Bethesda, Md., C1-1
S Yeong, Y Zhu, D Smith, C Verma, W Lim, B Tan, Q Li, N Cheung, M Cai, Y Zhu, S Zhou, S Tan, W Duan
(2006), Vol. 281, pp. 30768-30781, Journal of biological chemistry, Bethesda, Md, C1
Y Zhu, D Smith, C Verma, W Lim, B Tan, J Armstrong, S Zhou, E Chan, S Tan, Y Zhu, N Cheung, W Duan
(2006), Vol. 18, pp. 807-818, Cellular signalling, Amsterdam, Netherlands, C1-1
P Chang, J Mao, S Huang, L Ning, Z Wang, T On, W Duan, Y Zhu
(2006), Vol. 101, pp. 245-249, Journal of Pharmacological Sciences, Japan, C1-1
Drug-herb interactions: eliminating toxicity with hard drug design.
X Yang, Z Hu, W Duan, Y Zhu, S Zhou
(2006), Vol. 12, pp. 4649-4664, Current pharmaceutical design, Hilversum, The Netherlands, C1-1
Z Hu, X Yang, S Chan, A Xu, W Duan, Y Zhu, F Sheu, U Boelsterli, E Chan, Q Zhang, J Wang, P Rachel Ee, H Koh, M Huang, S Zhou
(2006), Vol. 216, pp. 225-237, Toxicology and applied pharmacology, San Diego Calif., C1-1
S Zhong, M Huang, X Yang, L Liang, Y Wang, M Romkes, W Duan, E Chan, S Zhou
(2006), Vol. 62, pp. 457-472, British journal of clinical pharmacology, London, England, C1-1
Intracellular drug delivery by sulfatide-mediated liposomes to gliomas
K Shao, Q Hou, W Duan, M Go, K Wong, Q Li
(2006), Vol. 115, pp. 150-157, Journal of controlled release, Amsterdam, The Netherlands, C1-1
Genetic polymorphisms of cytochrome P450 2B6 gene in Han Chinese
S Guan, M Huang, E Chan, X Chen, W Duan, S Zhou
(2006), Vol. 29, pp. 14-21, European journal of pharmaceutical sciences, Amsterdam, The Netherlands, C1-1
Pharmacokinetics of recombinant human endostatin in rats
X Yang, Z Hu, E Chan, W Duan, S Zhou
(2006), Vol. 7, pp. 565-576, Current drug metabolism, Hilversum, The Netherlands, C1-1
X Yang, Z Hu, A Xu, W Duan, Y Zhu, M Huang, F Sheu, Q Zhang, J Bian, E Chan, X Li, J Wang, S Zhou
(2006), Vol. 319, pp. 82-104, Journal of pharmacology and experimental therapeutics, Bethesda, Md., C1-1
Small interfering RNA-mediated silencing of cytochromeP450 3A4 gene
J Chen, X Yang, M Huang, Z Hu, M He, W Duan, E Chan, F Sheu, X Chen, S Zhou
(2006), Vol. 34, pp. 1650-1657, Drug metabolism and disposition, Bethesda, Md., C1-1
J Zhang, M Huang, S Guan, H Bi, Y Pan, W Duan, S Chan, X Chen, Y Hong, S Zhou
(2006), Vol. 317, pp. 1285-1294, Journal of pharmacology and experimental therapeutics, Bethesda, Md., C1-1
Early induction of chalpains in rotenone-mediated neuronal apoptosis
M Chen, Y Yap, M Choy, C Koh, S Seet, W Duan, M Whiteman, N Cheung
(2006), Vol. 397, pp. 69-73, Neuroscience letters, Limerick, Ireland, C1-1
M Whiteman, Y Chua, D Zhang, W Duan, Y Liou, J Armstrong
(2006), Vol. 339, pp. 255-262, Biochemical and biophysical research comminications, San Diego Calif., C1-1
Y Zhang, J Ding, W Duan
(2006), Vol. 32, pp. 1-9, Journal of biological physics: an intrnational journal for the formulation and application of physical and mathematical models in the biological sciences, Amsterdam, The Netherlands, C1-1
X Chen, Z Hu, X Yang, M Huang, Y Gao, W Tang, S Chan, X Dai, J Ye, P Ho, W Duan, H Yang, Y Zhu, S Zhou
(2006), Vol. 6, pp. 499-508, International immumopharmacology, Barking, England, C1-1
Topotecan is a substrate for multidrug resistance associated protein 4
Q Tian, J Zhang, S Chan, T Chin Tan, W Duan, M Huang, Y Zhu, E Chan, Q Yu, Y Nie, P Chi-Liu Ho, Q Li, K Ng, H Yang, H Wei, J Bian, S Zhou
(2006), Vol. 7, pp. 105-118, Current drug metabolism, Hilversum, Netherlands, C1-1
The very C-terminus of PRK1/PKN is essential for its activation by RhoA and downstream signaling
W Lim, B Tan, Y Zhu, S Zhou, J Armstrong, Q Li, Q Dong, E Chan, D Smith, C Verma, S Tan, W Duan
(2006), Vol. 18, pp. 1473-1481, Cellular signalling, Amsterdam, Netherlands, C1-1
E Chan, S Zhou, S Sahasranaman, W Duan
(2006), Vol. 23, pp. 729-741, Pharmaceutical research, New York, N.Y., C1-1
A comparison study of cerebral protection using Ginkgo biloba extract and Losartan on stroked rats
K Loh, L Low, W Wong, S Zhou, S Huang, R Silva, W Duan, W Chou, Y Zhu
(2006), Vol. 398, pp. 28-33, Neuroscienceletters, Limerick, Ireland, C1-1
C Koh, R Qi, D Qu, A Melendez, J Manikandan, B Bay, W Duan, N Cheung
(2006), Vol. 18, pp. 1572-1583, Cellular signalling, Amsterdam, Netherlands, C1-1
Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered Thalidomide
X Yang, Z Hu, S Chan, W Duan, P Ho, U Boelsterli, K Ng, E Chan, J Bian, Y Chen, M Huang, S Zhou
(2006), Vol. 7, pp. 431-454, Current drug metabolism, Hilversum, The Netherlands, C1-1
Induction of propranolol metabolism by Ginkgo biloba extract EGb 761 in rats
L Zhao, M Huang, J Chen, P Rachel Ee, E Chan, W Duan, Y Guan, Y Hong, X Chen, S Zhou
(2006), Vol. 7, pp. 577-587, Current drug metabolism, Hilversum, The Netherlands, C1-1
Relationship between genotype and enzyme activity of glutathione S-transferases M1 and P1 in Chinese
S Zhong, S Zhou, X Chen, S Chan, E Chan, K Ng, W Duan, M Huang
(2006), Vol. 28, pp. 77-85, European journal of pharmaceutical sciences, Amsterdam, The Nertherlands, C1-1
Y Zhu, W Lim, B Tan, T Teo, W Duan
(2005), Vol. 17, pp. 1125-1136, Cellular signalling, New York, N.Y., C1-1
The PKCÁ-D294G mutant found in pituitary and thyroid tumors fails to transduce extracellular signals
Y Zhu, Q Dong, B Tan, W Lim, S Zhou, W Duan
(2005), Vol. 65, pp. 4520-4524, Cancer research, Philadelphia, Pa., C1-1
Metabolism and transport of oxazaphosphorines and the clinical implications
J Zhang, Q Tian, Y Sui, C Shu, S Zhou, W Duan, Y Zhu
(2005), Vol. 37, pp. 611-703, Drug metabolism reviews, Abingdon, Eng., C1-1
J Sun, S Huang, B Tan, M Whiteman, Y Zhu, Y Wu, Y Ng, W Duan, Y Zhu
(2005), Vol. 76, pp. 2849-2860, Life sciences, Amsterdam, The Netherlands, C1-1
W Lim, Y Zhu, C Wang, B Tan, J Armstrong, T Dockland, H Yang, Y Zhu, T Teo, W Duan
(2005), Vol. 17, pp. 1084-1097, Cellular signalling, New York, N.Y., C1-1
Prediction of herb-drug metabolic interactions: a simulation study
S Zhou, M Huang, A Xu, H Yang, W Duan, J Paxton
(2005), Vol. 19, pp. 464-471, Phytotherapy research: an international journal devoted to mekical and scientific research on plants and plant products, Chichester, England, C1-1
X Yang, Z Hu, S Chan, B Goh, W Duan, E Chan, S Zhou
(2005), Vol. 821, pp. 221-228, Journal of chromatography. B, analytical technologies in the biomedical and life sciences, Amsterdam, The Netherlands, C1-1
P Wang, W Duan, A Munn, H Yang
(2005), Vol. 272, pp. 4703-4715, FEBS journal, London, England, C1-1
Y Zhang, J Ding, W Duan, W Fan
(2005), Vol. 26, pp. 406-411, Bioelectromagnetics, New York, N.Y., C1-1
Human multidrug resistance associated protein 4 resitance to camtothecins
Q Tian, J Zhang, T Tan, E Chan, W Duan, S Chan, U Boelsterli, P Ho, H Yang, J Bian, M Huang, Y Zhu, W Xiong, X Li, S Zhou
(2005), Vol. 22, pp. 1837-1853, Pharmaceutical research, New York, N.Y., C1-1
J Li, S Zhou, H Huynh, W Duan, E Chan
(2005), Vol. 22, pp. 1954-1963, Pharmaceutical research, Delft, The Netherlands, C1-1
Y Gao, H Gao, E Chan, W Tang, A Xu, H Yang, M Huang, J Ln, X Li, W Duan, C Xu, S Zhou
(2005), Vol. 34, pp. 171-198, Immunological investigations: a journal of molecular and cellular immunology, New York, N.Y., C1-1
Insights into exazaphosphorine resistance and possible approaches to its circumvention
J Zhang, Q Tian, S Chan, W Duan, S Zhou
(2005), Vol. 8, pp. 271-297, Drug resistance updates, Edinburgh, Scotland, C1-1
St Johns wort modulates the toxicities and parmacokinetics of CPT-11 (Irontecan) in rats
Z Hu, X Yang, P Ho, E Chan, S Chan, C Xu, X Li, Y Zhu, W Duan, X Chen, M Huang, H Yang, S Zhou
(2005), Vol. 22, pp. 902-914, Pharmaceutical research, Amsterdam, The Netherlands, C1-1
X Yang, Z Hu, S Chan, P Ho, E Chan, W Duan, B Goh, S Zhou
(2005), Vol. 39, pp. 299-304, Journal of pharmaceutical and biomedical analysis, Amsterdam, The Netherlands, C1-1
Herb-drug interactions: a literature review
Z Hu, X Yang, P Ho, S Chan, P Heng, E Chan, W Duan, H Koh, S Zhou
(2005), Vol. 65, pp. 1239-1282, Drugs, Auckland, New Zealand, C1-1
Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs
S Zhou, S Chan, B Goh, E Chan, W Duan, M Huang, H McLeod
(2005), Vol. 44, pp. 279-304, Clinical pharmacokinetics, Auckland, New Zealand, C1-1
Drug bioactivation, covalent binding to target proteins and toxicity relevance
S Zhou, E Chan, W Duan, M Huang, Y Chen
(2005), Vol. 37, pp. 41-213, Drug metabolism reviews, New York, N.Y., C1-1
Inhaled p38a mitogen-activated protein kinase antisense oligonucleotide attenuates asthma in mice
W Duan, J Chan, K McKay, J Crosby, H Choo, B Leung, J Karras, W Wong
(2005), Vol. 171, pp. 571-578, American journal of respiratory and critical care medicine, New York, N.Y., C1-1
Multidrug resistance proteins (MRPs) and implication in drug development
Q Tian, J Zhang, E Chan, W Duan, S Zhou
(2005), Vol. 64, pp. 1-18, Drug development research, New York, N.Y., C1-1
An anti-inflammatory role for a phosphoinositide 3-kinase inhibitor LY294002 in a mouse asthma model
W Duan, A Aguinaldo Datiles, B Leung, C Vlahos, W Wong
(2005), Vol. 5, pp. 495-502, International immunopharmacology, Amsterdam, The Netherlands, C1-1
The PKCa-D294G mutant found in pituitary and thyroid tumors fails to transduce extracellular signals
Y Zhu, Q Dong, B Tan, W Lim, S Zhou, W Duan
(2005), Vol. 65, pp. 4520-4524, Cancer research, Philadelphia, Pa., C1-1
Novel agents that potentially inhibit irinotecan-induced diarrhea
X Yang, Z Hu, S Chan, E Chan, B Goh, W Duan, S Zhou
(2005), Vol. 12, pp. 763-771, Current medicinal chemistry, Beijing, China, C1-1
Effects of Salvia miltiorrhiza after acute myocardial infarction in rats
X Ji, B Tan, S Huang, M Whiteman, Y Zhu, W Duan, Y Zhu, W Linz
(2004), pp. 183-195, Novel compounds from natural products in the new millennium, Singapore, B1-1
Y Zhu, D Stolz, F Guo, M Ross, S Watkins, B Tan, R Qi, E Manser, Q Li, B Bay, T Teo, W Duan
(2004), Vol. 18, pp. 1722-1724, The FASEB journal : official publication of the Federation of American Societies for experimental biology, Bethesda, Md., C1-1
The influence of magnetic fields exposure on neurite outgrowth in PC12 rat pheochromocytoma cells
W Fan, J Ding, W Duan, Y Zhu
(2004), Vol. 282, pp. 325-328, Journal of magnetism and magnetic materials, Amsterdam, The Netherlands, C1-1
Cytochrome bc1 regulates the mitochondrial permeability transition by two distinct pathways
J Armstrong, H Yang, W Duan, M Whiteman
(2004), Vol. 279, pp. 50420-50428, Journal of biological chemistry, Bethesda, Md., C1-1
W Duan, J Chan, C Wong, B Leung, W Wong
(2004), Vol. 172, pp. 7053-7059, Journal of immunology, Rockville, Md., C1-1
S Chue, C Seow, W Duan, K Yeo, A Koh, W Wong
(2004), Vol. 4, pp. 1089-1098, International immunopharmacology, Amsterdam, The Netherlands, C1-1
Antiinflammatory effects of genistein, a tyrosine kinase inhibitor, on a guinea pig model of asthma
W Duan, I Kuo, S Selvarajan, K Chua, B Bay, W Wong
(2003), Vol. 167, pp. 185-192, American journal of respiratory and critical care medicine, New York, N.Y., C1-1
Metallothionein 2A expression is associated with cell proliferation in breast cancer
R Jin, V Chow, P Tan, S Dheen, W Duan, B Bay
(2002), Vol. 23, pp. 81-86, Carcinogenesis, Oxford, England, C1-1
Identification of two proteins, S14 and UIP1, that interact with UCH37
T Li, W Duan, H Yang, M Lee, F Mustafa, B Lee, T Teo
(2001), Vol. 488, pp. 201-205, FEBS letters, Amsterdam, The Netherlands, C1-1
W Duan, B Sun, T Li, B Tan, M Lee, T Teo
(2000), Vol. 256, pp. 113-121, Gene, Amsterdam, The Netherlands, C1-1
C Brack, W Duan, A Hulbert, G Schreiber
(1995), Vol. 110, pp. 523-529, Comparative biochemistry and physiology - part b: biochemistry & molecular biology, Amsterdam, The Netherlands, C1-1
Binding of thyroxine to pig transthyretin, its cDNA structure, and other properties
W Duan, S Richardson, J Kohrle, L Chang, B Southwell, P Harms, C Brack, T Pettersson, G Schreiber
(1995), Vol. 230, pp. 977-986, European journal of biochemistry, Chichester, Eng., C1-1
D Walker, W Duan, E Popovic, A Kaye, F Tomlinson, M Lavin
(1995), Vol. 55, pp. 20-23, Cancer research, Philadelphia, Pa., C1-1
Evolution of transthyretin in marsupials
W Duan, S Richardson, J Babon, R Heyes, B Southwell, P Harms, R Wettenhall, K Dziegielewska, L Selwood, A Bradley, C Brack, G Schreiber
(1995), Vol. 227, pp. 396-406, European journal of biochemistry, Chichester, Eng., C1-1
Evolution of marsupial and other vertebrate thyroxine-binding plasma proteins
S Richardson, A Bradley, W Duan, R Wettenhall, P Harms, J Babon, B Southwell, S Nicol, S Donnellan, G Schreiber
(1994), Vol. 266, pp. R1359-R1370, American journal of physiology. Regulatory, integrative and comparative physiology, Bethesda, Md., C1-1
S Richardson, A Bradley, W Duan, B Southwell, L Selwood, G Schreiber
(1993), Vol. 90, pp. 177-182, General and Comparative Endocrinology, New York, N.Y., C1-1
Thyroxine Transport to the Brain: Role of Protein Synthesis by the Choroid Plexus
B Southwell, W Duan, D Alcorn, C Brack, S Richardson, J Kohrle, G Schreiber
(1993), Vol. 133, pp. 2116-2126, Endocrinology, Oxford, Eng., C1-1
Transthyretin gene expression in choroid plexus first evolved in reptiles
M Achen, W Duan, T Pettersson, P Harms, S Richardson, M Lawrence, R Wettenhall, A Aldred, G Schreiber
(1993), Vol. 265, pp. R982-R989, American Journal of Physiology, Bethesda, Md., C1-1
Expression of retinol-binding protein mRNA in mammalian choroid plexus
W Duan, G Schreiber
(1992), Vol. 101, pp. 399-406, Comparative Biochemistry and Physiology - Part B: Biochemistry & Molecular Biology, Amsterdam, The Netherlands, C1-1
Ontogenesis of transthyretin gene expression in chicken choroid plexus and liver
B SOUTHWELL, W DUAN, G TU, G SCHREIBER
(1991), Vol. 100, pp. 329-338, Comparative biochemistry and physiology part B: Comparative biochemistry, Amsterdam, The Netherlands, C1-1
W DUAN, M ACHEN, S RICHARDSON, M LAWRENCE, R WETTENHALL, A JAWOROWSKI, G SCHREIBER
(1991), Vol. 200, pp. 679-687, European journal of biochemistry, Chichester, Eng., C1-1
Funded Projects at Deakin
Australian Competitive Grants
A novel tumour-targeting nanoliposome drug delivery system for the treatment of malignant gliomas
Prof Wei Duan, A/Prof Andrew Danks, Prof Sing Lo, A/Prof Qiu Tian Li
NHMRC Project Grant
- 2010: $171,350
- 2009: $168,157
- 2008: $105,590
Developing molecularly targeted polymer nanoparticles for cancer therapeutics and diagnostics
Prof Wei Duan, Prof Qipeng Guo
DIISR/AISRF Grant - AISRF/India-Australian Strategic Research Fund - Department of Innovation, Industry, Science & Research
- 2010: $29,200
- 2009: $82,019
- 2007: $210,000
Smart bombing of cancer stem cells using aptamer-guided nanoliposomal siRNA
Prof Wei Duan, Prof Lingxue Kong
DIISR/AISRF Grant - AISRF/India-Australian Strategic Research Fund - Department of Innovation, Industry, Science & Research
- 2013: $75,000
- 2012: $68,000
- 2011: $112,000
- 2010: $145,000
Peptide-based Star Nanocarriers for Targeted Anticancer Drug Delivery
Prof Greg Qiao, Prof Wei Duan, Prof Kenneth Dawson
ARC - Discovery Projects
- 2016: $121,661
- 2015: $54,996
Collaborative workshop on MEMS and its application in health care
Prof Lingxue Kong, Prof Wei Duan, Prof Abbas Kouzani, Prof Johnson Mak, Dr Sugumar Dharmalingam
DIISR/AISRF Grant - AISRF/India-Australian Strategic Research Fund - Department of Innovation, Industry, Science & Research
- 2014: $31,000
Other Public Sector Funding
Link and Learn Grant
Prof Wei Duan
DHSV Victorian Cancer Agency - Department of Human Services Victoria
- 2008: $5,000
Establishment of an aptamer-based technology platform for molecular targetting of cancer stem cell
Prof Wei Duan, A/Prof Andrew Danks, A/Prof Q Dong, Prof Lingxue Kong, A/Prof Jun-Ping Liu, Dr Jane Dai, Prof Michael Famulok, Prof Dominique Joubert
DHSV Victorian Cancer Agency - Department of Human Services Victoria
- 2008: $136,346
Equipment Grant 2007
Prof Wei Duan
NHMRC - Equipment Grant (pre 2017)
- 2008: $81,082
Industry and Other Funding
Establishment of the First Medical School in Geelong
Prof Wei Duan, Prof Alister Ward, Prof Brendan Crotty
Geelong Community Foundation Grant - Research
- 2007: $30,000
Novel therapeutics to root out cancer
Prof Wei Duan
CASS Grant - Research - The CASS Foundation Limited
- 2014: $15,000
- 2013: $40,000
Tailored Neoadjuvant Epirubicin and Cyclophosphamide (EC) and Nanoparticle Albumin Bound (nab) Paclitaxel for Newly Diagnosed Breast Cancer
Dr Mustafa Khasraw, Prof Wei Duan
Specialised Therapeutics Australia Pty. Ltd
- 2014: $66,500
- 2013: $50,000
Glycomarker Panel for Prediction of IVF Outcome
Tracey Edgell, Prof Wei Duan
Merck Serono - Grant for Fertility Innovation GFI
- 2017: $1,000
- 2016: $56,618
- 2015: $55,043
Research into the role of Proteins called cytokine receptors in ovarian cancer and the development of novel agents to suppress their effects
Prof Alister Ward, Prof Wei Duan, Dr Daniel Mcculloch
Equity Trustees - Norman, Ann & Graeme Atkins Charitable Trust
- 2015: $12,500
- 2014: $12,500
- 2013: $12,500
Development of nanoparticle-based delivery systems for Artemisia flavonoids for the treatment of hepatitis B
Prof Wei Duan
The Xingjian Institute of Materia Medic
- 2018: $495
- 2017: $31,114
Development of novel aptamer-guided and exosome-based diagnostics and therapeutics
Prof Wei Duan
Suzhou Genepharma Co., Ltd.
- 2019: $80,000
- 2018: $79,970
- 2017: $80,000
Shanghai OneTar-Deakin Joint Laboratory of Personalised Precision Medicine.
Prof Wei Duan
Shanghai OneTar Biomedicine
- 2023: $40,000
- 2021: $70,000
Supervisions
Shweta Shashikant Patel
Thesis entitled: Aptamer-Based Molecular Pathology of Cancer
Doctor of Philosophy (Medicine), School of Medicine
Tuong Ngoc Gia Nguyen
Thesis entitled: Blueberry-derived extracellular vesicles as a novel nanobioplatform for immunotherapy
Doctor of Philosophy (Medicine), School of Medicine
Viet Pham
Thesis entitled: Small affinity probes for extracellular nanovesicle-based cancer liquid biopsy
Doctor of Philosophy (Medicine), School of Medicine
Mohammed Mehadi Hassan Chowdhury
Thesis entitled: PVA Coated Doxorubicin Loaded Zinc Ferrite Nanoparticles Against Liver Cancer
Doctor of Philosophy (Medicine), School of Medicine
Snehal Midge
Thesis entitled: Novel aptamers against HER-2 for liquid biopsy
Doctor of Philosophy (Medicine), School of Medicine
Hridika Talukder Barua
Thesis entitled: Development of a novel exosome-based liquid biopsy assay for early detection of pancreatic cancer
Doctor of Philosophy (Medicine), School of Medicine
Yumei Zhang
Thesis entitled: Development of CD81 aptamers for extracellular vesicle-based theranostics
Doctor of Philosophy (Medicine), School of Medicine
Wang Yin
Thesis entitled: Novel strategies to overcome drug resistance in liver cancer
Doctor of Philosophy (Medicine), School of Medicine
Hadi Al Shamaileh
Thesis entitled: Aptamer-mediated siRNA delivery to target colon cancer stem cells
Doctor of Philosophy (Medicine), School of Medicine
Dongxi Xiang
Thesis entitled: Developing RNA aptamer technology for targeting cancer stem cells
Doctor of Philosophy (Medicine), School of Medicine
Tao Wang
Thesis entitled: An aptamer-mediated siRNA delivery system targeting breast tumourigenic cells
Doctor of Philosophy (Medicine), School of Medicine
Manju Marappan
Thesis entitled: Efficacy of utilizing chemical antibodies in histopathological studies
MAppSc (Medicine) (High cost), School of Medicine
Jia Lin
Thesis entitled: A nanoliposome-based drug delivery system for cancer
Doctor of Philosophy (Medicine), School of Medicine
Michael Stewart
Thesis entitled: Molting and Reproduction in Portunus Pelagicus
Doctor of Philosophy (Medicine), School of Medicine
Yugandhar Arcot
Thesis entitled: Fabrication of polymeric microfluidic devices for blood plasma separation
Doctor of Philosophy (Engineering), Institute for Frontier Materials
Yajie Dong
Thesis entitled: Wet Spun Graphene/Polyurethane Fibres for Triboelectric Nanogenerators
Doctor of Philosophy (Engineering), Institute for Frontier Materials
Jianyang Zhao
Thesis entitled: Multi-Responsive Polymeric Biomaterials for Biomedical Applications
Doctor of Philosophy (Engineering), Institute for Frontier Materials
Hao Fang
Thesis entitled: The role of IL-6 family signalling components in ovarian cancer
Doctor of Philosophy (Medicine), School of Medicine
Joanna Michelle Macdonald
Thesis entitled: A bifunctional aptamer for the targeted treatment of brain metastases
Doctor of Philosophy (Medicine), School of Medicine
Xinchu Zhao
Thesis entitled: Gold Nanoparticles Based DNA Detection in Microfluidics
Doctor of Philosophy (Engineering), Institute for Frontier Materials
Lijue Chen
Thesis entitled: Delivery of Fluorouracil and siRNA by Mesoporous Silica Nanoparticles to Drug Resistant Colorectal Cancer
Doctor of Philosophy (Engineering), Institute for Frontier Materials
Xiaodong She
Thesis entitled: Tailored hollow mesoporous silica nanoplatforms with biological labels for colon targeted drug deliver systems
Doctor of Philosophy (Engineering), Institute for Frontier Materials
Daryoush Mortazavi
Thesis entitled: DESIGN, MODELLING, FABRICATION, AND EVALUATION OF A TUNEABLE LSPR DEVICE
Doctor of Philosophy (Engineering), School of Engineering
Yang Lim
Thesis entitled: Surface-Stress-Based Microcantilever Aptasensor
Doctor of Philosophy (Engineering), School of Engineering